Expanded Access to Telisotuzumab Adizutecan

NCT05982873 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Telisotuzumab Adizutecan

Sponsor

AbbVie